nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—ABCC2—Olmesartan—coronary artery disease	0.0843	0.123	CbGbCtD
Lomefloxacin—SLC22A5—Niacin—coronary artery disease	0.0751	0.109	CbGbCtD
Lomefloxacin—ABCC2—Telmisartan—coronary artery disease	0.0674	0.0983	CbGbCtD
Lomefloxacin—ABCC2—Pitavastatin—coronary artery disease	0.0674	0.0983	CbGbCtD
Lomefloxacin—ABCC2—Ezetimibe—coronary artery disease	0.0497	0.0725	CbGbCtD
Lomefloxacin—SLC22A5—Furosemide—coronary artery disease	0.0494	0.072	CbGbCtD
Lomefloxacin—ABCC2—Simvastatin—coronary artery disease	0.0462	0.0674	CbGbCtD
Lomefloxacin—ABCC2—Pravastatin—coronary artery disease	0.0452	0.0659	CbGbCtD
Lomefloxacin—ABCC2—Lovastatin—coronary artery disease	0.0452	0.0659	CbGbCtD
Lomefloxacin—ABCC2—Atorvastatin—coronary artery disease	0.0412	0.0601	CbGbCtD
Lomefloxacin—ABCC2—Furosemide—coronary artery disease	0.0385	0.0561	CbGbCtD
Lomefloxacin—CYP1A2—Gemfibrozil—coronary artery disease	0.0332	0.0484	CbGbCtD
Lomefloxacin—CYP1A2—Clopidogrel—coronary artery disease	0.0288	0.0419	CbGbCtD
Lomefloxacin—CYP1A2—Losartan—coronary artery disease	0.014	0.0205	CbGbCtD
Lomefloxacin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.000773	0.193	CbGdCrCtD
Lomefloxacin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	0.000689	0.172	CbGdCrCtD
Lomefloxacin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	0.000659	0.164	CbGdCrCtD
Lomefloxacin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	0.000659	0.164	CbGdCrCtD
Lomefloxacin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	0.000586	0.146	CbGdCrCtD
Lomefloxacin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	0.000377	0.0942	CbGdCrCtD
Lomefloxacin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	0.000262	0.0655	CbGdCrCtD
Lomefloxacin—Chest pain—Timolol—coronary artery disease	7.56e-05	0.000288	CcSEcCtD
Lomefloxacin—Myalgia—Timolol—coronary artery disease	7.56e-05	0.000288	CcSEcCtD
Lomefloxacin—Vomiting—Ezetimibe—coronary artery disease	7.54e-05	0.000288	CcSEcCtD
Lomefloxacin—Hypersensitivity—Pravastatin—coronary artery disease	7.54e-05	0.000288	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Perindopril—coronary artery disease	7.53e-05	0.000288	CcSEcCtD
Lomefloxacin—Anxiety—Timolol—coronary artery disease	7.53e-05	0.000287	CcSEcCtD
Lomefloxacin—Angioedema—Lisinopril—coronary artery disease	7.52e-05	0.000287	CcSEcCtD
Lomefloxacin—Pruritus—Olmesartan—coronary artery disease	7.52e-05	0.000287	CcSEcCtD
Lomefloxacin—Decreased appetite—Losartan—coronary artery disease	7.51e-05	0.000287	CcSEcCtD
Lomefloxacin—Abdominal pain—Captopril—coronary artery disease	7.5e-05	0.000286	CcSEcCtD
Lomefloxacin—Dizziness—Simvastatin—coronary artery disease	7.48e-05	0.000286	CcSEcCtD
Lomefloxacin—Rash—Ezetimibe—coronary artery disease	7.48e-05	0.000286	CcSEcCtD
Lomefloxacin—Dermatitis—Ezetimibe—coronary artery disease	7.47e-05	0.000285	CcSEcCtD
Lomefloxacin—Confusional state—Ramipril—coronary artery disease	7.47e-05	0.000285	CcSEcCtD
Lomefloxacin—Discomfort—Timolol—coronary artery disease	7.46e-05	0.000285	CcSEcCtD
Lomefloxacin—Asthenia—Niacin—coronary artery disease	7.45e-05	0.000285	CcSEcCtD
Lomefloxacin—Fatigue—Losartan—coronary artery disease	7.45e-05	0.000284	CcSEcCtD
Lomefloxacin—Headache—Ezetimibe—coronary artery disease	7.43e-05	0.000284	CcSEcCtD
Lomefloxacin—Malaise—Lisinopril—coronary artery disease	7.42e-05	0.000283	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Ramipril—coronary artery disease	7.41e-05	0.000283	CcSEcCtD
Lomefloxacin—Oedema—Ramipril—coronary artery disease	7.41e-05	0.000283	CcSEcCtD
Lomefloxacin—Vertigo—Lisinopril—coronary artery disease	7.4e-05	0.000282	CcSEcCtD
Lomefloxacin—Dry mouth—Timolol—coronary artery disease	7.39e-05	0.000282	CcSEcCtD
Lomefloxacin—Constipation—Losartan—coronary artery disease	7.39e-05	0.000282	CcSEcCtD
Lomefloxacin—Syncope—Lisinopril—coronary artery disease	7.38e-05	0.000282	CcSEcCtD
Lomefloxacin—Vomiting—Eplerenone—coronary artery disease	7.38e-05	0.000282	CcSEcCtD
Lomefloxacin—Feeling abnormal—Furosemide—coronary artery disease	7.38e-05	0.000282	CcSEcCtD
Lomefloxacin—Leukopenia—Lisinopril—coronary artery disease	7.37e-05	0.000281	CcSEcCtD
Lomefloxacin—Nausea—Fenofibrate—coronary artery disease	7.36e-05	0.000281	CcSEcCtD
Lomefloxacin—Pruritus—Niacin—coronary artery disease	7.35e-05	0.000281	CcSEcCtD
Lomefloxacin—Asthenia—Pravastatin—coronary artery disease	7.34e-05	0.00028	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Furosemide—coronary artery disease	7.32e-05	0.00028	CcSEcCtD
Lomefloxacin—Rash—Eplerenone—coronary artery disease	7.32e-05	0.000279	CcSEcCtD
Lomefloxacin—Urticaria—Perindopril—coronary artery disease	7.32e-05	0.000279	CcSEcCtD
Lomefloxacin—Hypersensitivity—Trandolapril—coronary artery disease	7.32e-05	0.000279	CcSEcCtD
Lomefloxacin—Dermatitis—Eplerenone—coronary artery disease	7.31e-05	0.000279	CcSEcCtD
Lomefloxacin—Diarrhoea—Valsartan—coronary artery disease	7.31e-05	0.000279	CcSEcCtD
Lomefloxacin—Confusional state—Timolol—coronary artery disease	7.3e-05	0.000279	CcSEcCtD
Lomefloxacin—Shock—Ramipril—coronary artery disease	7.29e-05	0.000278	CcSEcCtD
Lomefloxacin—Hypersensitivity—Enalapril—coronary artery disease	7.29e-05	0.000278	CcSEcCtD
Lomefloxacin—Abdominal pain—Perindopril—coronary artery disease	7.28e-05	0.000278	CcSEcCtD
Lomefloxacin—Diarrhoea—Olmesartan—coronary artery disease	7.27e-05	0.000278	CcSEcCtD
Lomefloxacin—Headache—Eplerenone—coronary artery disease	7.27e-05	0.000278	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Ramipril—coronary artery disease	7.25e-05	0.000277	CcSEcCtD
Lomefloxacin—Oedema—Timolol—coronary artery disease	7.24e-05	0.000276	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Timolol—coronary artery disease	7.24e-05	0.000276	CcSEcCtD
Lomefloxacin—Pruritus—Pravastatin—coronary artery disease	7.24e-05	0.000276	CcSEcCtD
Lomefloxacin—Loss of consciousness—Lisinopril—coronary artery disease	7.24e-05	0.000276	CcSEcCtD
Lomefloxacin—Nausea—Clopidogrel—coronary artery disease	7.23e-05	0.000276	CcSEcCtD
Lomefloxacin—Tachycardia—Ramipril—coronary artery disease	7.23e-05	0.000276	CcSEcCtD
Lomefloxacin—Skin disorder—Ramipril—coronary artery disease	7.2e-05	0.000275	CcSEcCtD
Lomefloxacin—Vomiting—Simvastatin—coronary artery disease	7.19e-05	0.000275	CcSEcCtD
Lomefloxacin—Hypersensitivity—Telmisartan—coronary artery disease	7.19e-05	0.000274	CcSEcCtD
Lomefloxacin—Cough—Lisinopril—coronary artery disease	7.18e-05	0.000274	CcSEcCtD
Lomefloxacin—Nausea—Lovastatin—coronary artery disease	7.18e-05	0.000274	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Ramipril—coronary artery disease	7.16e-05	0.000273	CcSEcCtD
Lomefloxacin—Rash—Simvastatin—coronary artery disease	7.13e-05	0.000272	CcSEcCtD
Lomefloxacin—Dermatitis—Simvastatin—coronary artery disease	7.13e-05	0.000272	CcSEcCtD
Lomefloxacin—Asthenia—Trandolapril—coronary artery disease	7.13e-05	0.000272	CcSEcCtD
Lomefloxacin—Shock—Timolol—coronary artery disease	7.13e-05	0.000272	CcSEcCtD
Lomefloxacin—Feeling abnormal—Losartan—coronary artery disease	7.12e-05	0.000272	CcSEcCtD
Lomefloxacin—Urticaria—Furosemide—coronary artery disease	7.11e-05	0.000272	CcSEcCtD
Lomefloxacin—Diarrhoea—Niacin—coronary artery disease	7.11e-05	0.000271	CcSEcCtD
Lomefloxacin—Asthenia—Enalapril—coronary artery disease	7.1e-05	0.000271	CcSEcCtD
Lomefloxacin—Headache—Simvastatin—coronary artery disease	7.09e-05	0.000271	CcSEcCtD
Lomefloxacin—Abdominal pain—Furosemide—coronary artery disease	7.08e-05	0.00027	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Losartan—coronary artery disease	7.07e-05	0.00027	CcSEcCtD
Lomefloxacin—Dizziness—Valsartan—coronary artery disease	7.06e-05	0.00027	CcSEcCtD
Lomefloxacin—Anorexia—Ramipril—coronary artery disease	7.06e-05	0.00027	CcSEcCtD
Lomefloxacin—Nausea—Ezetimibe—coronary artery disease	7.05e-05	0.000269	CcSEcCtD
Lomefloxacin—Skin disorder—Timolol—coronary artery disease	7.04e-05	0.000269	CcSEcCtD
Lomefloxacin—Dizziness—Olmesartan—coronary artery disease	7.03e-05	0.000268	CcSEcCtD
Lomefloxacin—Pruritus—Trandolapril—coronary artery disease	7.03e-05	0.000268	CcSEcCtD
Lomefloxacin—Chest pain—Lisinopril—coronary artery disease	7.01e-05	0.000268	CcSEcCtD
Lomefloxacin—Arthralgia—Lisinopril—coronary artery disease	7.01e-05	0.000268	CcSEcCtD
Lomefloxacin—Myalgia—Lisinopril—coronary artery disease	7.01e-05	0.000268	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Timolol—coronary artery disease	7e-05	0.000267	CcSEcCtD
Lomefloxacin—Asthenia—Telmisartan—coronary artery disease	7e-05	0.000267	CcSEcCtD
Lomefloxacin—Pruritus—Enalapril—coronary artery disease	7e-05	0.000267	CcSEcCtD
Lomefloxacin—Diarrhoea—Pravastatin—coronary artery disease	7e-05	0.000267	CcSEcCtD
Lomefloxacin—Anxiety—Lisinopril—coronary artery disease	6.98e-05	0.000267	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HK2—coronary artery disease	6.94e-05	0.00144	CbGpPWpGaD
Lomefloxacin—Discomfort—Lisinopril—coronary artery disease	6.93e-05	0.000264	CcSEcCtD
Lomefloxacin—Hypotension—Ramipril—coronary artery disease	6.92e-05	0.000264	CcSEcCtD
Lomefloxacin—Anorexia—Timolol—coronary artery disease	6.9e-05	0.000264	CcSEcCtD
Lomefloxacin—Pruritus—Telmisartan—coronary artery disease	6.9e-05	0.000264	CcSEcCtD
Lomefloxacin—Nausea—Eplerenone—coronary artery disease	6.9e-05	0.000263	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—NOS2—coronary artery disease	6.88e-05	0.00143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—coronary artery disease	6.87e-05	0.00143	CbGpPWpGaD
Lomefloxacin—Dizziness—Niacin—coronary artery disease	6.87e-05	0.000262	CcSEcCtD
Lomefloxacin—Urticaria—Losartan—coronary artery disease	6.86e-05	0.000262	CcSEcCtD
Lomefloxacin—Dry mouth—Lisinopril—coronary artery disease	6.85e-05	0.000262	CcSEcCtD
Lomefloxacin—Abdominal pain—Losartan—coronary artery disease	6.83e-05	0.000261	CcSEcCtD
Lomefloxacin—Asthenia—Captopril—coronary artery disease	6.81e-05	0.00026	CcSEcCtD
Lomefloxacin—Diarrhoea—Trandolapril—coronary artery disease	6.8e-05	0.000259	CcSEcCtD
Lomefloxacin—Vomiting—Valsartan—coronary artery disease	6.79e-05	0.000259	CcSEcCtD
Lomefloxacin—Confusional state—Lisinopril—coronary artery disease	6.77e-05	0.000259	CcSEcCtD
Lomefloxacin—Diarrhoea—Enalapril—coronary artery disease	6.77e-05	0.000258	CcSEcCtD
Lomefloxacin—Hypotension—Timolol—coronary artery disease	6.77e-05	0.000258	CcSEcCtD
Lomefloxacin—Dizziness—Pravastatin—coronary artery disease	6.76e-05	0.000258	CcSEcCtD
Lomefloxacin—Vomiting—Olmesartan—coronary artery disease	6.76e-05	0.000258	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.75e-05	0.000258	CcSEcCtD
Lomefloxacin—Rash—Valsartan—coronary artery disease	6.74e-05	0.000257	CcSEcCtD
Lomefloxacin—Dermatitis—Valsartan—coronary artery disease	6.73e-05	0.000257	CcSEcCtD
Lomefloxacin—Nausea—Simvastatin—coronary artery disease	6.72e-05	0.000257	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Lisinopril—coronary artery disease	6.72e-05	0.000256	CcSEcCtD
Lomefloxacin—Oedema—Lisinopril—coronary artery disease	6.72e-05	0.000256	CcSEcCtD
Lomefloxacin—Pruritus—Captopril—coronary artery disease	6.71e-05	0.000256	CcSEcCtD
Lomefloxacin—Rash—Olmesartan—coronary artery disease	6.7e-05	0.000256	CcSEcCtD
Lomefloxacin—Insomnia—Ramipril—coronary artery disease	6.7e-05	0.000256	CcSEcCtD
Lomefloxacin—Dermatitis—Olmesartan—coronary artery disease	6.7e-05	0.000256	CcSEcCtD
Lomefloxacin—Headache—Valsartan—coronary artery disease	6.69e-05	0.000255	CcSEcCtD
Lomefloxacin—Diarrhoea—Telmisartan—coronary artery disease	6.68e-05	0.000255	CcSEcCtD
Lomefloxacin—Headache—Olmesartan—coronary artery disease	6.66e-05	0.000254	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	6.66e-05	0.00138	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	6.66e-05	0.00138	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Ramipril—coronary artery disease	6.65e-05	0.000254	CcSEcCtD
Lomefloxacin—Shock—Lisinopril—coronary artery disease	6.61e-05	0.000252	CcSEcCtD
Lomefloxacin—Asthenia—Perindopril—coronary artery disease	6.61e-05	0.000252	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—coronary artery disease	6.61e-05	0.00137	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Ramipril—coronary artery disease	6.61e-05	0.000252	CcSEcCtD
Lomefloxacin—Vomiting—Niacin—coronary artery disease	6.6e-05	0.000252	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Timolol—coronary artery disease	6.6e-05	0.000252	CcSEcCtD
Lomefloxacin—Hypersensitivity—Furosemide—coronary artery disease	6.6e-05	0.000252	CcSEcCtD
Lomefloxacin—Somnolence—Ramipril—coronary artery disease	6.59e-05	0.000251	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Lisinopril—coronary artery disease	6.58e-05	0.000251	CcSEcCtD
Lomefloxacin—Dizziness—Trandolapril—coronary artery disease	6.57e-05	0.000251	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PSMB5—coronary artery disease	6.56e-05	0.00136	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PSMA6—coronary artery disease	6.56e-05	0.00136	CbGpPWpGaD
Lomefloxacin—Tachycardia—Lisinopril—coronary artery disease	6.56e-05	0.00025	CcSEcCtD
Lomefloxacin—Insomnia—Timolol—coronary artery disease	6.55e-05	0.00025	CcSEcCtD
Lomefloxacin—Rash—Niacin—coronary artery disease	6.55e-05	0.00025	CcSEcCtD
Lomefloxacin—Dermatitis—Niacin—coronary artery disease	6.54e-05	0.00025	CcSEcCtD
Lomefloxacin—Dizziness—Enalapril—coronary artery disease	6.54e-05	0.00025	CcSEcCtD
Lomefloxacin—Skin disorder—Lisinopril—coronary artery disease	6.53e-05	0.000249	CcSEcCtD
Lomefloxacin—Dyspepsia—Ramipril—coronary artery disease	6.52e-05	0.000249	CcSEcCtD
Lomefloxacin—Pruritus—Perindopril—coronary artery disease	6.52e-05	0.000249	CcSEcCtD
Lomefloxacin—Headache—Niacin—coronary artery disease	6.51e-05	0.000248	CcSEcCtD
Lomefloxacin—Paraesthesia—Timolol—coronary artery disease	6.5e-05	0.000248	CcSEcCtD
Lomefloxacin—Vomiting—Pravastatin—coronary artery disease	6.5e-05	0.000248	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Lisinopril—coronary artery disease	6.5e-05	0.000248	CcSEcCtD
Lomefloxacin—Diarrhoea—Captopril—coronary artery disease	6.49e-05	0.000248	CcSEcCtD
Lomefloxacin—Dyspnoea—Timolol—coronary artery disease	6.46e-05	0.000246	CcSEcCtD
Lomefloxacin—Dizziness—Telmisartan—coronary artery disease	6.45e-05	0.000246	CcSEcCtD
Lomefloxacin—Rash—Pravastatin—coronary artery disease	6.45e-05	0.000246	CcSEcCtD
Lomefloxacin—Dermatitis—Pravastatin—coronary artery disease	6.44e-05	0.000246	CcSEcCtD
Lomefloxacin—Decreased appetite—Ramipril—coronary artery disease	6.44e-05	0.000246	CcSEcCtD
Lomefloxacin—Somnolence—Timolol—coronary artery disease	6.44e-05	0.000246	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—coronary artery disease	6.43e-05	0.00133	CbGpPWpGaD
Lomefloxacin—Asthenia—Furosemide—coronary artery disease	6.43e-05	0.000245	CcSEcCtD
Lomefloxacin—Headache—Pravastatin—coronary artery disease	6.41e-05	0.000245	CcSEcCtD
Lomefloxacin—Anorexia—Lisinopril—coronary artery disease	6.4e-05	0.000244	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—GSK3B—coronary artery disease	6.39e-05	0.00133	CbGpPWpGaD
Lomefloxacin—Fatigue—Ramipril—coronary artery disease	6.39e-05	0.000244	CcSEcCtD
Lomefloxacin—Dyspepsia—Timolol—coronary artery disease	6.38e-05	0.000243	CcSEcCtD
Lomefloxacin—Hypersensitivity—Losartan—coronary artery disease	6.37e-05	0.000243	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GCLM—coronary artery disease	6.36e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—coronary artery disease	6.35e-05	0.00132	CbGpPWpGaD
Lomefloxacin—Nausea—Valsartan—coronary artery disease	6.35e-05	0.000242	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—CREB1—coronary artery disease	6.34e-05	0.00131	CbGpPWpGaD
Lomefloxacin—Pruritus—Furosemide—coronary artery disease	6.34e-05	0.000242	CcSEcCtD
Lomefloxacin—Constipation—Ramipril—coronary artery disease	6.34e-05	0.000242	CcSEcCtD
Lomefloxacin—Nausea—Olmesartan—coronary artery disease	6.32e-05	0.000241	CcSEcCtD
Lomefloxacin—Vomiting—Trandolapril—coronary artery disease	6.31e-05	0.000241	CcSEcCtD
Lomefloxacin—Diarrhoea—Perindopril—coronary artery disease	6.3e-05	0.000241	CcSEcCtD
Lomefloxacin—Decreased appetite—Timolol—coronary artery disease	6.3e-05	0.00024	CcSEcCtD
Lomefloxacin—Vomiting—Enalapril—coronary artery disease	6.29e-05	0.00024	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—coronary artery disease	6.28e-05	0.0013	CbGpPWpGaD
Lomefloxacin—Hypotension—Lisinopril—coronary artery disease	6.28e-05	0.00024	CcSEcCtD
Lomefloxacin—Dizziness—Captopril—coronary artery disease	6.27e-05	0.00024	CcSEcCtD
Lomefloxacin—Rash—Trandolapril—coronary artery disease	6.26e-05	0.000239	CcSEcCtD
Lomefloxacin—Dermatitis—Trandolapril—coronary artery disease	6.26e-05	0.000239	CcSEcCtD
Lomefloxacin—Fatigue—Timolol—coronary artery disease	6.24e-05	0.000238	CcSEcCtD
Lomefloxacin—Rash—Enalapril—coronary artery disease	6.24e-05	0.000238	CcSEcCtD
Lomefloxacin—Dermatitis—Enalapril—coronary artery disease	6.23e-05	0.000238	CcSEcCtD
Lomefloxacin—Headache—Trandolapril—coronary artery disease	6.22e-05	0.000238	CcSEcCtD
Lomefloxacin—Vomiting—Telmisartan—coronary artery disease	6.2e-05	0.000237	CcSEcCtD
Lomefloxacin—Asthenia—Losartan—coronary artery disease	6.2e-05	0.000237	CcSEcCtD
Lomefloxacin—Headache—Enalapril—coronary artery disease	6.2e-05	0.000237	CcSEcCtD
Lomefloxacin—Nausea—Niacin—coronary artery disease	6.17e-05	0.000236	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP11B2—coronary artery disease	6.16e-05	0.00128	CbGpPWpGaD
Lomefloxacin—Rash—Telmisartan—coronary artery disease	6.15e-05	0.000235	CcSEcCtD
Lomefloxacin—Dermatitis—Telmisartan—coronary artery disease	6.15e-05	0.000235	CcSEcCtD
Lomefloxacin—Diarrhoea—Furosemide—coronary artery disease	6.13e-05	0.000234	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.12e-05	0.000234	CcSEcCtD
Lomefloxacin—Pruritus—Losartan—coronary artery disease	6.11e-05	0.000233	CcSEcCtD
Lomefloxacin—Headache—Telmisartan—coronary artery disease	6.11e-05	0.000233	CcSEcCtD
Lomefloxacin—Feeling abnormal—Ramipril—coronary artery disease	6.11e-05	0.000233	CcSEcCtD
Lomefloxacin—Dizziness—Perindopril—coronary artery disease	6.09e-05	0.000233	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP11B2—coronary artery disease	6.08e-05	0.00126	CbGpPWpGaD
Lomefloxacin—Insomnia—Lisinopril—coronary artery disease	6.08e-05	0.000232	CcSEcCtD
Lomefloxacin—Nausea—Pravastatin—coronary artery disease	6.08e-05	0.000232	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Ramipril—coronary artery disease	6.06e-05	0.000231	CcSEcCtD
Lomefloxacin—Paraesthesia—Lisinopril—coronary artery disease	6.03e-05	0.00023	CcSEcCtD
Lomefloxacin—Vomiting—Captopril—coronary artery disease	6.03e-05	0.00023	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—coronary artery disease	6.03e-05	0.00125	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Lisinopril—coronary artery disease	5.99e-05	0.000229	CcSEcCtD
Lomefloxacin—Rash—Captopril—coronary artery disease	5.98e-05	0.000228	CcSEcCtD
Lomefloxacin—Dermatitis—Captopril—coronary artery disease	5.98e-05	0.000228	CcSEcCtD
Lomefloxacin—Somnolence—Lisinopril—coronary artery disease	5.97e-05	0.000228	CcSEcCtD
Lomefloxacin—Feeling abnormal—Timolol—coronary artery disease	5.97e-05	0.000228	CcSEcCtD
Lomefloxacin—Headache—Captopril—coronary artery disease	5.94e-05	0.000227	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Timolol—coronary artery disease	5.92e-05	0.000226	CcSEcCtD
Lomefloxacin—Dizziness—Furosemide—coronary artery disease	5.92e-05	0.000226	CcSEcCtD
Lomefloxacin—Dyspepsia—Lisinopril—coronary artery disease	5.91e-05	0.000226	CcSEcCtD
Lomefloxacin—Diarrhoea—Losartan—coronary artery disease	5.91e-05	0.000226	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	5.9e-05	0.00122	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	5.9e-05	0.00122	CbGpPWpGaD
Lomefloxacin—Nausea—Trandolapril—coronary artery disease	5.9e-05	0.000225	CcSEcCtD
Lomefloxacin—Urticaria—Ramipril—coronary artery disease	5.89e-05	0.000225	CcSEcCtD
Lomefloxacin—Nausea—Enalapril—coronary artery disease	5.88e-05	0.000224	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PSMA6—coronary artery disease	5.87e-05	0.00122	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PSMB5—coronary artery disease	5.87e-05	0.00122	CbGpPWpGaD
Lomefloxacin—Vomiting—Perindopril—coronary artery disease	5.86e-05	0.000224	CcSEcCtD
Lomefloxacin—Abdominal pain—Ramipril—coronary artery disease	5.86e-05	0.000224	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	5.84e-05	0.00121	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Lisinopril—coronary artery disease	5.84e-05	0.000223	CcSEcCtD
Lomefloxacin—Rash—Perindopril—coronary artery disease	5.81e-05	0.000222	CcSEcCtD
Lomefloxacin—Dermatitis—Perindopril—coronary artery disease	5.8e-05	0.000222	CcSEcCtD
Lomefloxacin—Nausea—Telmisartan—coronary artery disease	5.8e-05	0.000221	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—coronary artery disease	5.79e-05	0.0012	CbGpPWpGaD
Lomefloxacin—Fatigue—Lisinopril—coronary artery disease	5.79e-05	0.000221	CcSEcCtD
Lomefloxacin—Headache—Perindopril—coronary artery disease	5.77e-05	0.00022	CcSEcCtD
Lomefloxacin—Urticaria—Timolol—coronary artery disease	5.75e-05	0.00022	CcSEcCtD
Lomefloxacin—Constipation—Lisinopril—coronary artery disease	5.75e-05	0.000219	CcSEcCtD
Lomefloxacin—Abdominal pain—Timolol—coronary artery disease	5.73e-05	0.000219	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	5.72e-05	0.00119	CbGpPWpGaD
Lomefloxacin—Dizziness—Losartan—coronary artery disease	5.71e-05	0.000218	CcSEcCtD
Lomefloxacin—Vomiting—Furosemide—coronary artery disease	5.69e-05	0.000217	CcSEcCtD
Lomefloxacin—Rash—Furosemide—coronary artery disease	5.65e-05	0.000216	CcSEcCtD
Lomefloxacin—Dermatitis—Furosemide—coronary artery disease	5.64e-05	0.000215	CcSEcCtD
Lomefloxacin—Nausea—Captopril—coronary artery disease	5.64e-05	0.000215	CcSEcCtD
Lomefloxacin—Headache—Furosemide—coronary artery disease	5.61e-05	0.000214	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—SULT1A1—coronary artery disease	5.6e-05	0.00116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GPX2—coronary artery disease	5.59e-05	0.00116	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	5.58e-05	0.00116	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	5.55e-05	0.00115	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Lisinopril—coronary artery disease	5.54e-05	0.000211	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GGT1—coronary artery disease	5.53e-05	0.00115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GPX4—coronary artery disease	5.52e-05	0.00115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—SULT1A1—coronary artery disease	5.52e-05	0.00115	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—coronary artery disease	5.52e-05	0.00114	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Lisinopril—coronary artery disease	5.49e-05	0.00021	CcSEcCtD
Lomefloxacin—Vomiting—Losartan—coronary artery disease	5.49e-05	0.00021	CcSEcCtD
Lomefloxacin—Nausea—Perindopril—coronary artery disease	5.47e-05	0.000209	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTA1—coronary artery disease	5.47e-05	0.00113	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Ramipril—coronary artery disease	5.46e-05	0.000208	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HK1—coronary artery disease	5.45e-05	0.00113	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	5.45e-05	0.00113	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	5.45e-05	0.00113	CbGpPWpGaD
Lomefloxacin—Rash—Losartan—coronary artery disease	5.45e-05	0.000208	CcSEcCtD
Lomefloxacin—Dermatitis—Losartan—coronary artery disease	5.44e-05	0.000208	CcSEcCtD
Lomefloxacin—Headache—Losartan—coronary artery disease	5.41e-05	0.000207	CcSEcCtD
Lomefloxacin—Urticaria—Lisinopril—coronary artery disease	5.34e-05	0.000204	CcSEcCtD
Lomefloxacin—Hypersensitivity—Timolol—coronary artery disease	5.34e-05	0.000204	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—coronary artery disease	5.32e-05	0.0011	CbGpPWpGaD
Lomefloxacin—Nausea—Furosemide—coronary artery disease	5.32e-05	0.000203	CcSEcCtD
Lomefloxacin—Asthenia—Ramipril—coronary artery disease	5.32e-05	0.000203	CcSEcCtD
Lomefloxacin—Abdominal pain—Lisinopril—coronary artery disease	5.31e-05	0.000203	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	5.27e-05	0.00109	CbGpPWpGaD
Lomefloxacin—Pruritus—Ramipril—coronary artery disease	5.24e-05	0.0002	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.23e-05	0.00108	CbGpPWpGaD
Lomefloxacin—Asthenia—Timolol—coronary artery disease	5.2e-05	0.000198	CcSEcCtD
Lomefloxacin—Nausea—Losartan—coronary artery disease	5.13e-05	0.000196	CcSEcCtD
Lomefloxacin—Pruritus—Timolol—coronary artery disease	5.12e-05	0.000196	CcSEcCtD
Lomefloxacin—Diarrhoea—Ramipril—coronary artery disease	5.07e-05	0.000194	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—coronary artery disease	4.97e-05	0.00103	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Timolol—coronary artery disease	4.96e-05	0.000189	CcSEcCtD
Lomefloxacin—Hypersensitivity—Lisinopril—coronary artery disease	4.95e-05	0.000189	CcSEcCtD
Lomefloxacin—Dizziness—Ramipril—coronary artery disease	4.9e-05	0.000187	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	4.89e-05	0.00101	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—coronary artery disease	4.86e-05	0.00101	CbGpPWpGaD
Lomefloxacin—Asthenia—Lisinopril—coronary artery disease	4.82e-05	0.000184	CcSEcCtD
Lomefloxacin—Dizziness—Timolol—coronary artery disease	4.79e-05	0.000183	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	4.76e-05	0.000987	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND2—coronary artery disease	4.76e-05	0.000986	CbGpPWpGaD
Lomefloxacin—Pruritus—Lisinopril—coronary artery disease	4.75e-05	0.000181	CcSEcCtD
Lomefloxacin—Vomiting—Ramipril—coronary artery disease	4.71e-05	0.00018	CcSEcCtD
Lomefloxacin—Rash—Ramipril—coronary artery disease	4.67e-05	0.000178	CcSEcCtD
Lomefloxacin—Dermatitis—Ramipril—coronary artery disease	4.67e-05	0.000178	CcSEcCtD
Lomefloxacin—Headache—Ramipril—coronary artery disease	4.64e-05	0.000177	CcSEcCtD
Lomefloxacin—Vomiting—Timolol—coronary artery disease	4.61e-05	0.000176	CcSEcCtD
Lomefloxacin—Diarrhoea—Lisinopril—coronary artery disease	4.6e-05	0.000175	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2B—coronary artery disease	4.58e-05	0.000949	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—coronary artery disease	4.57e-05	0.000947	CbGpPWpGaD
Lomefloxacin—Rash—Timolol—coronary artery disease	4.57e-05	0.000174	CcSEcCtD
Lomefloxacin—Dermatitis—Timolol—coronary artery disease	4.56e-05	0.000174	CcSEcCtD
Lomefloxacin—Headache—Timolol—coronary artery disease	4.54e-05	0.000173	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GPX3—coronary artery disease	4.54e-05	0.00094	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—coronary artery disease	4.51e-05	0.000935	CbGpPWpGaD
Lomefloxacin—Dizziness—Lisinopril—coronary artery disease	4.44e-05	0.00017	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—ALDH2—coronary artery disease	4.41e-05	0.000914	CbGpPWpGaD
Lomefloxacin—Nausea—Ramipril—coronary artery disease	4.4e-05	0.000168	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	4.39e-05	0.000909	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—coronary artery disease	4.33e-05	0.000897	CbGpPWpGaD
Lomefloxacin—Nausea—Timolol—coronary artery disease	4.3e-05	0.000164	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2C19—coronary artery disease	4.3e-05	0.000891	CbGpPWpGaD
Lomefloxacin—Vomiting—Lisinopril—coronary artery disease	4.27e-05	0.000163	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2C19—coronary artery disease	4.24e-05	0.000879	CbGpPWpGaD
Lomefloxacin—Rash—Lisinopril—coronary artery disease	4.24e-05	0.000162	CcSEcCtD
Lomefloxacin—Dermatitis—Lisinopril—coronary artery disease	4.23e-05	0.000162	CcSEcCtD
Lomefloxacin—Headache—Lisinopril—coronary artery disease	4.21e-05	0.000161	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—coronary artery disease	4.19e-05	0.00087	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	4.18e-05	0.000867	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2CA—coronary artery disease	4.17e-05	0.000864	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	4.15e-05	0.00086	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GCLC—coronary artery disease	4.15e-05	0.00086	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—coronary artery disease	4.13e-05	0.000857	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—coronary artery disease	4.12e-05	0.000853	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	4.08e-05	0.000846	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—coronary artery disease	4.05e-05	0.000839	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CETP—coronary artery disease	4.03e-05	0.000836	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—coronary artery disease	4.03e-05	0.000834	CbGpPWpGaD
Lomefloxacin—Nausea—Lisinopril—coronary artery disease	3.99e-05	0.000152	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—coronary artery disease	3.82e-05	0.000793	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.82e-05	0.000791	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	3.81e-05	0.00079	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCS2—coronary artery disease	3.79e-05	0.000786	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GK—coronary artery disease	3.79e-05	0.000786	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	3.74e-05	0.000775	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PPP2CA—coronary artery disease	3.73e-05	0.000772	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—coronary artery disease	3.68e-05	0.000763	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—coronary artery disease	3.65e-05	0.000758	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	3.56e-05	0.000737	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	3.56e-05	0.000737	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.55e-05	0.000737	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—UGCG—coronary artery disease	3.47e-05	0.000719	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—coronary artery disease	3.41e-05	0.000706	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB1—coronary artery disease	3.31e-05	0.000686	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	3.24e-05	0.000672	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GGT1—coronary artery disease	3.24e-05	0.000671	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—coronary artery disease	3.13e-05	0.000648	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—coronary artery disease	3.07e-05	0.000636	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	3.03e-05	0.000628	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLG—coronary artery disease	3.02e-05	0.000627	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA5B—coronary artery disease	2.94e-05	0.000609	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—coronary artery disease	2.92e-05	0.000605	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—coronary artery disease	2.92e-05	0.000605	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—coronary artery disease	2.91e-05	0.000603	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.89e-05	0.000599	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—coronary artery disease	2.87e-05	0.000594	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.79e-05	0.000578	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—coronary artery disease	2.76e-05	0.000571	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	2.74e-05	0.000568	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOB—coronary artery disease	2.67e-05	0.000554	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—coronary artery disease	2.67e-05	0.000554	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.65e-05	0.000549	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—coronary artery disease	2.64e-05	0.000546	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	2.63e-05	0.000545	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	2.58e-05	0.000534	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	2.58e-05	0.000534	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	2.53e-05	0.000524	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKMT1B—coronary artery disease	2.5e-05	0.000518	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	2.37e-05	0.000491	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	2.37e-05	0.000491	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—coronary artery disease	2.3e-05	0.000478	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	2.3e-05	0.000476	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	2.3e-05	0.000476	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—coronary artery disease	2.29e-05	0.000475	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	2.18e-05	0.000451	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	2.18e-05	0.000451	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	2.18e-05	0.000451	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	2.15e-05	0.000446	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	2.15e-05	0.000446	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	2.13e-05	0.000441	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.11e-05	0.000438	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	2.08e-05	0.000431	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—coronary artery disease	2.06e-05	0.000427	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPAP2B—coronary artery disease	2.04e-05	0.000422	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKM—coronary artery disease	2.04e-05	0.000422	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UQCRFS1—coronary artery disease	2.04e-05	0.000422	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	1.99e-05	0.000413	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	1.95e-05	0.000405	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	1.92e-05	0.000397	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PYGM—coronary artery disease	1.89e-05	0.000393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKMT2—coronary artery disease	1.89e-05	0.000393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SULT4A1—coronary artery disease	1.89e-05	0.000393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH6A1—coronary artery disease	1.89e-05	0.000393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PDK4—coronary artery disease	1.89e-05	0.000393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—POMC—coronary artery disease	1.89e-05	0.000391	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—coronary artery disease	1.81e-05	0.000375	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDHA—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMGCS2—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GK—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GYG1—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PFKM—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GATM—coronary artery disease	1.69e-05	0.00035	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—coronary artery disease	1.67e-05	0.000347	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	1.65e-05	0.000342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	1.65e-05	0.000342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	1.65e-05	0.000342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	1.64e-05	0.00034	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	1.63e-05	0.000338	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK1—coronary artery disease	1.62e-05	0.000335	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCH1—coronary artery disease	1.61e-05	0.000334	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AK1—coronary artery disease	1.61e-05	0.000334	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	1.59e-05	0.00033	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	1.57e-05	0.000326	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MDH2—coronary artery disease	1.54e-05	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UGCG—coronary artery disease	1.54e-05	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPAT—coronary artery disease	1.54e-05	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCD1—coronary artery disease	1.54e-05	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PGM1—coronary artery disease	1.49e-05	0.000308	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.45e-05	0.000301	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.44e-05	0.000298	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKB—coronary artery disease	1.44e-05	0.000298	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PYGB—coronary artery disease	1.44e-05	0.000298	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM2—coronary artery disease	1.35e-05	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DLAT—coronary artery disease	1.35e-05	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COX5B—coronary artery disease	1.35e-05	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLIN1—coronary artery disease	1.35e-05	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PFKFB3—coronary artery disease	1.35e-05	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.28e-05	0.000266	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SULT1E1—coronary artery disease	1.28e-05	0.000265	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.24e-05	0.000258	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1B1—coronary artery disease	1.22e-05	0.000253	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HK2—coronary artery disease	1.22e-05	0.000253	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC27A1—coronary artery disease	1.17e-05	0.000243	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CPT1B—coronary artery disease	1.15e-05	0.000238	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LCAT—coronary artery disease	1.15e-05	0.000238	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA4—coronary artery disease	1.13e-05	0.000234	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.11e-05	0.000229	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PDHA1—coronary artery disease	1.09e-05	0.000226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCLM—coronary artery disease	1.09e-05	0.000226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.05e-05	0.000219	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP11B2—coronary artery disease	1.05e-05	0.000218	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TXNRD1—coronary artery disease	1.05e-05	0.000218	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC22A3—coronary artery disease	1.04e-05	0.000215	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HADH—coronary artery disease	1.02e-05	0.000212	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ARNTL—coronary artery disease	1.02e-05	0.000212	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.01e-05	0.000209	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	9.83e-06	0.000204	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	9.7e-06	0.000201	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX2—coronary artery disease	9.7e-06	0.000201	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA2—coronary artery disease	9.7e-06	0.000201	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG5—coronary artery disease	9.58e-06	0.000199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HK1—coronary artery disease	9.58e-06	0.000199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SULT1A1—coronary artery disease	9.58e-06	0.000199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX4—coronary artery disease	9.58e-06	0.000199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	9.57e-06	0.000198	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HADHA—coronary artery disease	9.47e-06	0.000196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA1—coronary artery disease	9.36e-06	0.000194	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPA—coronary artery disease	9.25e-06	0.000192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCB3—coronary artery disease	8.96e-06	0.000186	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA5—coronary artery disease	8.87e-06	0.000184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—P4HB—coronary artery disease	8.7e-06	0.00018	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	8.62e-06	0.000179	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	8.54e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	8.44e-06	0.000175	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	8.34e-06	0.000173	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—VCAN—coronary artery disease	8.05e-06	0.000167	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDOA—coronary artery disease	7.99e-06	0.000166	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DCN—coronary artery disease	7.75e-06	0.000161	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH2—coronary artery disease	7.54e-06	0.000156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.35e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HBA1—coronary artery disease	7.35e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LIPC—coronary artery disease	7.35e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2C19—coronary artery disease	7.35e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	7.35e-06	0.000152	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOC3—coronary artery disease	7.3e-06	0.000151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDLR—coronary artery disease	7.26e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.25e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC9A1—coronary artery disease	7.17e-06	0.000149	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—coronary artery disease	7.17e-06	0.000149	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CETP—coronary artery disease	7.09e-06	0.000147	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCLC—coronary artery disease	7.09e-06	0.000147	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SDC1—coronary artery disease	7.01e-06	0.000145	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PSMB5—coronary artery disease	6.62e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PSMA6—coronary artery disease	6.62e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.61e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CTGF—coronary artery disease	6.47e-06	0.000134	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GOT2—coronary artery disease	6.41e-06	0.000133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMGCR—coronary artery disease	6.41e-06	0.000133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCB1—coronary artery disease	5.9e-06	0.000122	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.78e-06	0.00012	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCA1—coronary artery disease	5.72e-06	0.000118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GOT1—coronary artery disease	5.54e-06	0.000115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GGT1—coronary artery disease	5.54e-06	0.000115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—coronary artery disease	4.97e-06	0.000103	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	4.93e-06	0.000102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—coronary artery disease	4.9e-06	0.000102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAT—coronary artery disease	4.84e-06	0.0001	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOB—coronary artery disease	4.7e-06	9.74e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—coronary artery disease	4.57e-06	9.47e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPL—coronary artery disease	4.49e-06	9.3e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX1—coronary artery disease	4.38e-06	9.07e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD36—coronary artery disease	4.26e-06	8.83e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP2CA—coronary artery disease	4.21e-06	8.72e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—coronary artery disease	4.04e-06	8.37e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGT—coronary artery disease	3.84e-06	7.95e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOE—coronary artery disease	3.76e-06	7.79e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA1—coronary artery disease	3.72e-06	7.7e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.56e-06	7.38e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—coronary artery disease	3.27e-06	6.79e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—POMC—coronary artery disease	3.23e-06	6.7e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—coronary artery disease	2.94e-06	6.1e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—coronary artery disease	2.82e-06	5.84e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.58e-06	5.34e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.58e-06	3.29e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—coronary artery disease	1.29e-06	2.68e-05	CbGpPWpGaD
